Comparing a marginal structural model with a Cox proportional hazard model to estimate the effect of time-dependent drug use in observational studies: statin use for primary prevention of cardiovascular disease as an example from the Rotterdam Study

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   CIRCULATION

The Rotterdam Study: 2014 objectives and design update

(2013) Albert Hofman et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Aspirin in the primary prevention of cardiovascular disease in the Women’s Health Study: Effect of noncompliance

(2012) Nancy R. Cook et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study

(2012) Maarten J. G. Leening et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008

(2012) Renske G. Wieberdink et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Future Directions for Cardiovascular Disease Comparative Effectiveness Research

(2012) Mark A. Hlatky et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Why We Still Need Randomized Trials to Compare Effectiveness

(2012) Laura Mauri   NEW ENGLAND JOURNAL OF MEDICINE

Personalized Prediction of Lifetime Benefits with Statin Therapy for Asymptomatic Individuals: A Modeling Study

(2012) Bart S. Ferket et al.   PLOS MEDICINE

Differences Between Marginal Structural Models and Conventional Models in Their Exposure Effect Estimates

(2011) David Suarez et al.   EPIDEMIOLOGY

Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients

(2011) Edward J. Mills et al.   EUROPEAN HEART JOURNAL

An overview of the objectives of and the approaches to propensity score analyses

(2011) Georg Heinze et al.   EUROPEAN HEART JOURNAL

Statin usage and all-cause and disease-specific mortality in a nationwide study

(2011) Jari Haukka et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Observational data for comparative effectiveness research: An emulation of randomised trials of statins and primary prevention of coronary heart disease

(2011) Goodarz Danaei et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies

(2010) B. H. Ch. Stricker et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Age Disparities in Heart Failure Research

(2010) Dalane W. Kitzman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Relation between three classes of structural models for the effect of a time-varying exposure on survival

(2009) Jessica G. Young et al.   LIFETIME DATA ANALYSIS

Patients Enrolled in Large Randomized Clinical Trials of Antiplatelet Treatment for Prevention After Transient Ischemic Attack or Ischemic Stroke Are Not Representative of Patients in Clinical Practice

(2009) Lisette Maasland et al.   STROKE